Stocktoria

INVO Fertility, Inc. IVF

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2008-11-11

INVO Fertility, Inc. financials (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Revenue$6.8M$6.6M$3.0M$822,196$4.2M
Gross profit$490,673$4.0M
R&D expense$4,880$165,945$544,043$216,430
SG&A expense$7.7M$8.1M$7.5M$10.0M$9.0M
Operating income-$7.2M-$6.6M-$6.8M-$10.6M-$5.2M
Interest expense$1.1M$925,909$59,445$1.3M
Income tax-$150,371$140,202$27,786$2,872$4,764
Net income-$23.3M-$9.3M-$8.0M-$10.9M-$6.7M
EPS (diluted)$-214.64$-3782.65$-67.37$-17.97$-0.63
Operating cash flow-$7.0M-$3.0M-$4.8M-$6.6M-$6.0M
Free cash flow-$7.1M-$3.2M-$5.2M-$6.6M-$6.4M
Cash & equivalents$5.7M
Inventory$225,253$219,764$264,507$263,602$287,773
Total assets$20.2M$46.1M$18.5M$4.1M$10.5M
Total liabilities$13.0M$26.0M$17.6M$5.1M$3.2M
Shareholders' equity$7.2M$12.6M$892,825-$977,612$7.3M

Source: SEC EDGAR filings · CIK 0001417926 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.